Insider · CIK 0001182615
MAIER PAUL V
Reports to the SEC for 11 companies · SAN DIEGO, CA
Transactions
50
Companies
11
Filings
8
CIK
0001182615
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-16 | ISCOInternational Stem Cell CORP · Stock OptionsD Disposition to Issuer | — |
| 2026-09-11 | ISCOInternational Stem Cell CORPS Sale | −$10.5K |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$189K |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$189K |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.S Sale | −$7,906.56 |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.S Sale | −$812K |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.S Sale | −$812K |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$91.4K |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.S Sale | −$2.13M |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc. · Employee Stock OptionM Exercise/Conversion | — |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.S Sale | −$7,906.56 |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc. · Employee Stock OptionM Exercise/Conversion | — |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc.S Sale | −$2.13M |
| 2026-08-28 | ETONEton Pharmaceuticals, Inc. · Employee Stock OptionM Exercise/Conversion | — |
| 2026-07-31 | ETONEton Pharmaceuticals, Inc. · Common StockA Award | — |
| 2026-06-11 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2026-06-11 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2026-01-12 | ETONEton Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2026-01-12 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2025-06-17 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2025-06-17 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2024-06-11 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2024-06-11 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2024-03-07 | Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-03-07 | Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-03-07 | Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer | — |
| 2024-02-13 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2023-06-14 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2023-06-14 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2023-06-07 | Ambrx Biopharma Cayman, Inc.A Award | — |
| 2023-03-03 | ETONEton Pharmaceuticals, Inc. · Stock Option(Right to buy)A Award | — |
| 2023-01-27 | Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award | — |
| 2023-01-27 | Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award | — |
| 2023-01-27 | Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-01-27 | Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2022-06-09 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2022-06-09 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2022-02-07 | ETONEton Pharmaceuticals, Inc. · Stock Option(Right to buy)A Award | — |
| 2021-06-09 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2021-06-09 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2021-05-03 | ETONEton Pharmaceuticals, Inc. · Stock Option(Right to buy)A Award | — |
| 2020-06-23 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2020-06-23 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2020-06-23 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2020-03-12 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2020-01-15 | FFRFF EAI Robotics Ecosystem Inc. · Non-qualified Stock Option (Right to Buy)A Award | — |
| 2019-06-03 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2019-06-03 | ISCOInternational Stem Cell CORP · Stock Option (Right to Buy)A Award | — |
| 2019-04-18 | ISCOInternational Stem Cell CORPS Sale | −$1,680.75 |
Recent filings
- 4MAIER PAUL V0001683168-26-007223SEC(opens sec.gov)
- 4MAIER PAUL V0001683168-26-007164SEC(opens sec.gov)
- 4/AMAIER PAUL V0001437749-26-029308SEC(opens sec.gov)
- 4MAIER PAUL V0001437749-26-029196SEC(opens sec.gov)
- 4MAIER PAUL V0001437749-26-025700SEC(opens sec.gov)
- 4MAIER PAUL V0001683168-26-005073SEC(opens sec.gov)
- 4MAIER PAUL V0001437749-26-001294SEC(opens sec.gov)
- 4MAIER PAUL V0001683168-25-004620SEC(opens sec.gov)
Companies
- Ambrx Biopharma Cayman, Inc.Director
- Ambrx Biopharma, Inc.Director
- Eton Pharmaceuticals, Inc.DirectorETON
- FF EAI Robotics Ecosystem Inc.DirectorFFR
- International Stem Cell CORPDirectorISCO
- LIGAND PHARMACEUTICALS INCSr. V-P, CFOLGND
- MABVAX THERAPEUTICS HOLDINGS, INC.Director
- PURE BIOSCIENCE, INC.DirectorPURE
- SEELOS THERAPEUTICS, INC.Director
- SEQUENOM INCChief Financial Officer
- Talon Therapeutics, Inc.Director
Address
C/O INTERNATIONAL STEM CELL CORP. 9745 BUSINESSPARK AVE.
SAN DIEGO, CA, 92131